Wave life sciences announces new data for leading rna editing capability across multiple tissues and provides update on aatd program during analyst and investor research webcast

Durable adar editing in vivo in preclinical models, including in cns tissues with editing out to at least four months

WVE Ratings Summary

WVE Quant Ranking